Hello World!

Published by Christin Glorioso

Dr. Christin Glorioso is a neuroscientist, physician, and serial entrepreneur. She is Co-founder and CEO of NeuroAge Therapeutics and Founder and Executive Director of Longevity Global. An expert in predictive modeling, Her COVID-19 US case prediction model was #1 out 104 teams worldwide in the XPRIZE Pandemic Response Challenge. Previously she was Head of Research of the DICE Institute at the Pathcheck Foundation, Head of AI of the COVIDB division at TeachAids, and Chief Strategist of UCSF’s Bakar Aging Research Institute. She has published more than 30 peer reviewed articles and been awarded fellowships by AFAR, the Glenn Foundation for Medical Research, and the National Institute on Aging. Dr. Glorioso holds an MD and PhD in Neuroscience from the University of Pittsburgh and Carnegie Mellon University’s Medical Scientist Training Program and completed her postdoctoral training at MIT. NeuroAge (https://www.neuroagetx.com/) is a San Francisco-based longevity techbio that is reversing brain aging in order to prevent dementia. The NeuroAge Test can tell you how old your brain is and your future risk of dementia more than 30 years ahead of time. We offer personalized recommendations to slow down or reverse your brain aging. Reach out to me if you are curious if the NeuroAge Test is right for you, if you would like to partner with us, or if you are interested in investing. View more posts